TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: percent of time in target glycemic range
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: behavioral feeding problems
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HPV vaccine acceptance rate
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Decrease in ART
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Prevalence of CAM use among respondents with self-reported allergies
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: TR deterioration rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean serum bicarbonate increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with serum bicarbonate <22 mmol/L
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Moderate to severe cerebral palsy
Endpoint domain: Mortality/survival
Primary endpoint: Initiating treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attending a postpartum obstetrics visit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Receiving contraception
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Full-time employment rates
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Earnings
Endpoint domain: Life impact
Endpoint subdomain: Economic functioning
Primary endpoint: Presentation of BP to the hospital
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Usage of analgesia epidural
Endpoint domain: Adverse events/effects
Primary endpoint: Initiation of breastfeeding in the delivery room
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: thromboembolic events risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to first flatus and bowel movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Investigator’s Global Assessment 0/1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dermatology Life Quality Index 0/1
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Compliance with Standard Precaution Scale scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lymph node invasion (LNI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: visual function parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: analgesia scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lung deposition of inhaled salbutamol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Systemic bioavailability of salbutamol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Kidney composite end point
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: muscle hardness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: subjective muscle stiffness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lung volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: DOSS values improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CRF (cardiorespiratory fitness)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: any-grade treatment-related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: grade 3-5 treatment-related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: pCR rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: BP ascertainment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion meeting ACOG recommendations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean VALS improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Central retinal thickness (CST)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment burden
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Tumor Recurrence Rate (TRR)
Endpoint domain: Mortality/survival
Primary endpoint: combined NP score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oral bioavailability of remimazolam
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sedative effects of remimazolam
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: diagnosis of clinically significant prostate cancer (csPCa)
Endpoint domain: Mortality/survival
Primary endpoint: Early mild AD prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mild cognitive impairment prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Amyloid positivity rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: 24-h diastolic BP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Success rate of post‐pyloric feeding tube placement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participant understanding of consent information
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: lateral weight shifting to the nonparetic side
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: center‐of‐pressure moving distance to the nonparetic side
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC glucose from baseline to week 18
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Two-hour post-dose fasting plasma glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: level of pain perception
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in life situation or condition after intervention
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Pregnancy-related Anxiety Questionnaire scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: sun protection product use behaviours
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: sun avoidance behaviours
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: behaviours related to protecting themselves and their children from the sun
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: change in central adiposity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: behavioral changes
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: cfDNA reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: syndecan-1 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: anatomical success after 3 months of follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: gap detection thresholds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: speech recognition scores under noisy conditions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time from ultrasound to extubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fewer volume changes in subcortical structures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: metabolic stability (smallest percent decline in metabolism)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Emergency Room (ER) admissions
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Mean total visit charge
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Sum of wRVUs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Unpaid claims
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Mean reduction in peak intraocular pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: 90-day sepsis-specific mortality
Endpoint domain: Mortality/survival
Primary endpoint: incidence of neo-MHV thrombosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Implementation of PPI recommendations
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Impact on study recruitment
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: PPI participants' confidence
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: CSS score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-perceived physical health
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: improvements in MVPA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduction in average shipment-related study drug stock-out
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: reduction in median transit-time for sites associated with a depot
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Incidence of acne
Endpoint domain: Adverse events/effects
Primary endpoint: Norfolk Quality of Life-Diabetic Neuropathy score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: EuroQoL 5-dimensions 5-levels score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Composite Autonomic Symptom Score-31
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Success rate of obturator canal enhancement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stigmatizing views toward eating disorders
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean change in exercise time at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean BAT scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: neonatal haemoglobin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: risk for cardiovascular death or heart failure hospitalization
Endpoint domain: Mortality/survival
Primary endpoint: Adhesion index (AI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: newly detected atrial fibrillation (AF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: modified Rankin Scale (mRS) score 0-1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recurrence of Congenital Heart Block (CHB)
Endpoint domain: Mortality/survival
Primary endpoint: cumulative consumption of oxycodone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ability to walk the day after surgery
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Contracture formation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: microscopic lung injury score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: proinflammatory cytokines
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: caspase‐3 determination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: drop in depression scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Posttreatment increase in SPL (dB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cannabis use willingness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: 10-year costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: DIL volumes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: apparent diffusion coefficient (ADC) values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in differential stress-induced activation in the right supracallosal ACC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Safe lengthening achievement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in total 25-hydroxyvitamin D levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Median VRC07‐523LS concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median PGT121 concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: High physical activity participation
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Healthy diet practice
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Breast self-exam practice
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Diagnostic accuracy for predicting fibrosis F ≥ 2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of G2 or 3 Radiation Dermatitis (RD)
Endpoint domain: Adverse events/effects
Primary endpoint: Combined patient and health care provider score using Radiation‐Induced Skin Reaction Assessment Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Individual items on the Radiation‐Induced Skin Reaction Assessment Scale (blistering/peeling, erythema, pigmentation, edema)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: SARS-CoV-2 neutralizing antibody level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: REV-ERBα gene expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: REV-ERBα/BMAL1 ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients achieving BP goal of <140/90 mm Hg
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Vresorb
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pairway
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-perceived effects on pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-perceived effects on health
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Behavior/attitude changes
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Kidney discard rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Medicine score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Endurance of trunk muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Improvement in standing posture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total unit score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: anatomy practical scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: written final examination scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of PMI
Endpoint domain: Mortality/survival
Primary endpoint: Need for re-operations for bleeding or tamponade
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: body appreciation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean SPPB scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time in functional recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percent employed/in school
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Quit smoking
Endpoint domain: Mortality/survival
Primary endpoint: incidence of suture-related complications
Endpoint domain: Adverse events/effects
Primary endpoint: clinical and functional symptoms improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fine Motor Skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of headache before and after treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in bite force (BF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in salivary cortisol levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: subjective satisfaction with the training method
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: threat appraisals
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: asthma health outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: mean serum endocan level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: social communication
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Reduction in missed HPV vaccine opportunities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall Response Rate at Week 24 (ORRWk24)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mini-Mental State Exam score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: serum brain-derived neurotrophic factor (BDNF) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: KI scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum levels of FSH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Healthy Purchasing Score (HPS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 2015 Healthy Eating Index score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Menstrual care skill scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in cost per participant
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Completion of the continuum of maternal healthcare services
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: words-in-noise perception
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-reported hearing difficulty
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: dual-task performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: WPAI (Work Productivity and Activity Impairment)
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: SGAP (Subjective Global Assessment of Pain)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total cumulative scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: scores for the station of calculating body mass index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: long-term optimal IOP response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: drops/surgery-free survival time
Endpoint domain: Mortality/survival
Primary endpoint: Plasma FPG reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Plasma TG reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Plasma LDL-C reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Heavy menstrual bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: nVAS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative incidence of dementia
Endpoint domain: Mortality/survival
Primary endpoint: iatrogenic preterm labor (iPTL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: BMI decrease greater than or equal to 0.25 SD scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neurocognitive parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Behavioral parameters
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cumulative incidence of POAG in 1 or both eyes
Endpoint domain: Mortality/survival
Primary endpoint: Cumulative incidence of visual field loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: PAC-SYM score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ∆CD4 lymphocyte count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Pain-related interference with activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes